Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

H. Wander · SciRah

Researcher profile · Semantic Scholar

H. Wander

Share profile

H. Wander — researcher profile on SciRah

h-index: 8
Works: 38
Citations: 343

Most-cited papers

Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer
W. Holtkamp, G. Nagel, H. Wander, H. Rauschecker +1 more
1984International Journal of Cancer95 citations
Semantic Scholar
Pharmacokinetic and pharmacodynamic basis for the treatment of metastatic breast cancer with high‐dose medroxyprogesterone acetate
Hans Christian Blossey, H. Wander, J. Koebberling, G. Nagel
1984Cancer74 citations
Semantic Scholar
Aminoglutethimide in the treatment of premenopausal patients with metastatic breast cancer.
H. Wander, H.Ch. Blossey, G. Nagel
1986European Journal of Cancer and Clinical Oncology44 citations
Semantic Scholar
First hemodialysis access selection varies with patient acuity.
A. Friedman, C. Walworth, C. Meehan, H. Wander +6 more
2000Advances in Renal Replacement Therapy31 citations
Semantic Scholar
Phase II study of aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer.
G. Nagel, H. Wander, H. Blossey
1982Cancer Research23 citations
Semantic Scholar
Clinical significance of circulating immune complexes in patients with metastatic breast cancer
G. Krieger, A. Kehl, H. Wander, A. Salo +2 more
1983International Journal of Cancer13 citations
Semantic Scholar
A long-acting depot preparation of a synthetic GnRH agonist (zoladex) in the treatment of pre- and postmenopausal advanced breast cancer (BC)
H. Wander, U. Kleeberg, E. Schachner-Wünschmann, G. Nagel
19878 citations
Semantic Scholar
Aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer: A phase II study of the association of medical oncology of the German cancer society (AIO)
H. Wander, G. Nagel, H. Blossey, U. Kleeberg
1986Cancer8 citations Open access
Semantic Scholar
[Megestrol acetate in various doses in the treatment of metastatic breast carcinoma--clinical and endocrinologic studies].
H. Wander, H. Blossey, G. Nagel, D. Emrich
1985Klinische Wochenschrift8 citations
Semantic Scholar
[Hyperprolactinemia in metastasizing breast cancer].
G. Nagel, H. Wander, H. Blossey
1981Swiss medical weekly8 citations
Semantic Scholar
[Determination of the carcinoembryonic antigen (CEA) for predicting the success of therapy in metastatic breast cancer].
G. Krieger, H. Wander, M. Prangen, G. Bandlow +2 more
2008Deutsche Medizinische Wochenschrift7 citations
Semantic Scholar
Phase II study with etoposide in previously untreated advanced breast cancer
H. Wander, W. Rauschning, D. Meyer, W. Achterrath +1 more
2004Cancer Chemotherapy and Pharmacology4 citations
Semantic Scholar
Hochdosiertes Medroxyprogesteronacetat beim metastasierenden Mammakarzinom: Beziehung zwischen Krankheitsverlauf und Hormonprofilen
H. Wander, C. Blossey, J. Köbberling, G. Nagel
1983Klinische Wochenschrift4 citations
Semantic Scholar
Metastatic breast cancer with constantly low CEA blood levels
G. Krieger, H. Wander, M. Kneba, M. Prangen +2 more
1984Journal of Cancer Research and Clinical Oncology3 citations Open access
Semantic Scholar
[High dose medroxyprogesterone acetate in metastatic breast cancer. Comparative clinical, pharmacokinetic and pharmacodynamic data of different forms of administration].
H. Blossey, H. Wander, G. Nagel, J. Köbberling +1 more
1982Onkologie3 citations
Semantic Scholar
4 Megestrol acetate versus medroxyprogesterone acetate in the treatment of metastatic breast cancer
H. Wander, U. Kleeberg, E. Gärtner, J. Hartlapp +3 more
19872 citations
Semantic Scholar
Megestrolazetat in verschiedenen Dosierungen bei der Behandlung des metastasierenden Mammakarzinoms — Klinische und endokrinologische Untersuchungen
H. Wander, H. Blossey, G. Nagel, D. Emrich
1985Klinische Wochenschrift2 citations
Semantic Scholar
[Aminoglutethimide plus high-dose medroxyprogesterone acetate versus aminoglutethimide plus cortisone in therapy of metastasizing breast cancer. An AIO phase III study].
H. Wander, U. Kleeberg, U. Essers, H. Blossey +1 more
1987Onkologie1 citations
Semantic Scholar
[Megestrol acetate versus medroxyprogesterone acetate in the treatment of metastasizing breast cancers. Intermediate report of a multicenter phase III study].
H. Wander, U. Kleeberg, E. Gärtner, J. Hartlapp +3 more
1987Onkologie1 citations
Semantic Scholar
[Importance of prolactin determination in metastatic breast cancer].
H. Wander, W. Holtkamp, G. Nagel
1984Deutsche Medizinische Wochenschrift1 citations
Semantic Scholar
430 Hyperprolactinemia in Metastatic Breast Cancer
W. Holtkamp, H. Wander, Dorit Heyden, H. Rauschecker +1 more
19831 citations
Semantic Scholar
[High dose medroxyprogesteroneacetate in metastasizing breast cancer: correlations between course of the disease and hormone profiles].
H. Wander, C. Blossey, J. Köbberling, G. Nagel
1983Klinische Wochenschrift1 citations
Semantic Scholar
Subject Index Vol. 18, 1995
Hartmut Goldschmidt, U. Hegenbart, R. Haas, W. Hunstein +46 more
19950 citations Open access
Semantic Scholar
Single-Agent Carboplatin Chemotherapy in Patients with Advanced Breast Cancer
H. Günter, H. Wander, G. Nagel, R. Lellé +4 more
19950 citations
Semantic Scholar
8 Myeloprotective effect of medroxyprogesterone acetate (MPA) on committed granulupoietic stemcells under cytotoxic chemotherapy
U. Kleeberg, H. Wander, P. Schneider, P. Kern
19870 citations
Semantic Scholar
The prognostic influence of hormone receptors on the survival of patients with metastatic breast cancer
H. Wander, G. Nagel
19870 citations
Semantic Scholar
Intensive short-term chemotherapy in patients with advanced breast cancer
H. Wander, G. Nagel, H. Luig, D. Emrich
1987Klinische Wochenschrift0 citations
Semantic Scholar
[Responsible risks in the choice of palliative chemotherapy].
G. Nagel, H. Wander
1986Onkologie0 citations
Semantic Scholar
Characterization of a monoclonal antibody against medroxyprogesterone acetate (MPA)
H. Blossey, H. Wander, S. Lichter, F. Kohen +2 more
1986Journal of Cancer Research and Clinical Oncology0 citations Open access
Semantic Scholar
Differential Significance of Prolactin Elevation in Patients with Metastatic Breast Cancer Treated with Medroxyprogesterone Acetate in High Dosage
H. C. Blossey, H. Wander, W. Holtkamp, G. Nagel
19860 citations
Semantic Scholar
Metergoline in breast cancer associated with hyperprolactinaemia: A phase II trial
W. Holtkamp, G. Nagel, H. Wander
1986Journal of Cancer Research and Clinical Oncology0 citations Open access
Semantic Scholar
[Changes in serum lipoproteins under hormonal therapy of breast carcinoma and other endocrine-dependent tumors].
H. Wander, A. Teichmann, P. Cremer, H. Wieland +4 more
1985Onkologie0 citations
Semantic Scholar
Zur Biologie der Mammakarzinome
G. Nagel, H. Wander, W. Holtkamp
19850 citations
Semantic Scholar
Inhalt, Vol. 5, Supplement 1, 1982
H. Wander, G. Nagel, H. C. Blossey, U. Kleeberg +18 more
19820 citations Open access
Semantic Scholar
[Combined drug/hormone therapy in metastatic breast cancer with vincristine, adriamycin, cyclophosphamide and high dose medroxyprogesterone acetate--VAC-MAP. Preliminary results of a phase II study of the German Cancer Society's Internal Medicine Oncology Task Force].
H. Wander, G. Nagel, H. Blossey, F. Kordilla +3 more
1982Onkologie0 citations
Semantic Scholar
[Medroxyprogesterone acetate (MAP) and aminoglutethimide (AG) in metastatic breast carcinoma. Preliminary report on a phase II study of the German Cancer Society's Internal Medicine Oncology Task Force].
H. Wander, G. Nagel, H. Blossey
1982Onkologie0 citations
Semantic Scholar
[Medroxyprogesterone acetate as glucocorticoid in combination with aminoglutethimide in the treatment of metastatic breast cancer].
H. Blossey, H. Wander, G. Nagel, J. Köbberling +1 more
1982Onkologie0 citations
Semantic Scholar
[Vindesine and adriamycin in the therapy of metastatic breast cancer].
H. Wander, G. Nagel
1982Onkologie0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

G. Nagel×29
Invite
G. Nagel — researcher profile on SciRah
H. Blossey×9
Invite
H. Blossey — researcher profile on SciRah
U. Kleeberg×8
Invite
U. Kleeberg — researcher profile on SciRah
J. Köbberling×6
Invite
J. Köbberling — researcher profile on SciRah

×5

Invite

W. Holtkamp — researcher profile on SciRah

Invite

G. Nagel — researcher profile on SciRah

H. Rauschecker×3

Invite

H. Rauschecker — researcher profile on SciRah

Invite

G. Krieger — researcher profile on SciRah

Invite

G. Nagel — researcher profile on SciRah

Invite

D. Emrich — researcher profile on SciRah

Invite

M. Prangen — researcher profile on SciRah

Invite

C. Blossey — researcher profile on SciRah